Guide · Updated November 2026

How to Talk to Your Doctor About GLP-1 Medications

Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are the best-known GLP-1 drugs. Only Wegovy and Zepbound are FDA-approved for weight management, in adults with obesity or with overweight plus at least one weight-related condition. Ozempic and Mounjaro are approved for type 2 diabetes (see the Ozempic and Mounjaro labels). In SURMOUNT-1, tirzepatide produced 20.9% average weight loss at the 15 mg dose over 72 weeks. Coming to your visit with your numbers, your history and your insurance details makes the conversation faster and more useful.

Bringing up weight loss medication with your doctor can feel awkward. I put it off for months before finally asking about Mounjaro. I had convinced myself the conversation would be embarrassing, that my doctor would judge me, or that I would get dismissed with “just eat less and move more.”

None of that happened. But the appointment went well partly because I showed up prepared. This guide covers exactly what to bring, what to say, and how to handle the common objections.

Why the Conversation Feels Hard

Most people do not struggle with the medical part. They struggle with the social part. There is a weird stigma around asking for help with weight, even in a doctor’s office.

Here is the thing: GLP-1 drugs are now widely prescribed, and most primary care doctors have had this conversation many times. You are not the first person to ask, and you will not be the last.

The difference between a productive appointment and a frustrating one almost always comes down to preparation.

Before Your Appointment: What to Prepare

Walking in with data changes the entire dynamic. Your doctor cannot dismiss a request backed by specific numbers the same way they can dismiss a vague “I want to try Ozempic.”

1. Know Your Numbers

Bring these to your appointment:

• Your BMI. The weight-loss trials behind Wegovy and Zepbound enrolled adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition like high blood pressure, high cholesterol or sleep apnea, per the Zepbound label and STEP 1. Use our body composition calculator to get a baseline.
• Your weight history. How long you have been at your current weight, your highest and lowest adult weights, and any previous weight loss attempts (diets, programs, other medications).
• Your comorbidities. High blood pressure, prediabetes, type 2 diabetes, sleep apnea, PCOS, high cholesterol. These are not just health concerns. Many insurers ask about them when they review coverage.
• Recent lab work. If you have had bloodwork in the past 6 months, bring the results. If not, your doctor will likely order some before prescribing.

2. Know What You Want to Ask About

Be specific. “I want to discuss GLP-1 medications” is better than “I want to lose weight.” Even better: “I have been researching semaglutide and tirzepatide and want to discuss whether I am a candidate.”

You do not need to have a preference between medications to start the conversation, but knowing the basics helps. Here is a quick comparison of the main options:

Lilly also sells a separate daily GLP-1 pill, Foundayo (orforglipron), approved for weight management.

For a deeper comparison, see our Mounjaro vs Ozempic breakdown.

3. Know Your Insurance Situation

Call your insurance company before the appointment and ask:

• “Does my plan cover GLP-1 medications for weight loss?”
• “Which medications are on formulary?” (Some plans cover Wegovy but not Zepbound, or vice versa.)
• “Is prior authorization required?”
• “Are there step therapy requirements?” (meaning you must try other options first)

This information saves your doctor time and lets them prescribe something your insurance will actually cover. If your plan does not cover GLP-1s at all, you still have options through cash-pay telehealth providers and manufacturer savings programs. Our insurance coverage guide has the full details, and the cost guide breaks down every pricing path.

What to Say: Scripts That Work

You do not need to memorize anything. But having a few phrases ready helps when the moment comes and your brain goes blank.

The Opening

Pick the one that fits your style:

• Direct: “I want to discuss GLP-1 medications for weight management. I have done some research and I think I may be a candidate.”
• Data-driven: “My BMI is [X], I have [condition], and I have tried [diet/exercise/program] without sustained results. I would like to discuss whether semaglutide or tirzepatide might be appropriate.”
• Question-based: “I have been reading about GLP-1 medications like Ozempic and Mounjaro. Can we talk about whether one of those would make sense for me?”

All three work. The common thread is being specific and framing it as a medical conversation, not a personal failing.

If Your Doctor Asks “What Have You Already Tried?”

This question is coming. It is not meant to make you feel bad. Doctors ask because GLP-1s are usually prescribed after lifestyle changes have been insufficient, and insurers often require documented prior attempts.

Be honest and specific:

• “I tracked calories at 1,500 per day for 6 months in 2024 and lost 15 pounds but regained it within 4 months.”
• “I have been exercising 4 days per week for the past year. My fitness has improved but my weight has not changed.”
• “I tried [program name] and lost X pounds but could not maintain it.”

The pattern matters more than the details. What doctors are listening for is evidence that you have made real effort and that the problem is biological, not motivational.

Common Doctor Objections (and How to Respond)

Not every doctor will say yes immediately. Some have reservations. Knowing the common pushbacks and having calm, informed responses makes a real difference.

”Let’s try diet and exercise first.”

What to say: “I have been trying that for [X months/years]. I can share my food logs and exercise history. The clinical trials for these medications (STEP 1, SURMOUNT-1) included lifestyle intervention alongside medication. I am not looking to replace diet and exercise. I am looking for a tool that makes those efforts more effective.”

This is the most common objection. Both the STEP 1 trial and the SURMOUNT-1 trial gave every participant, including the medication groups, lifestyle counseling on diet and physical activity. The labels say these drugs are meant to be used with a reduced-calorie diet and more activity. GLP-1 medications are add-ons to lifestyle changes, not replacements.

”These medications have serious side effects.”

What to say: “I have read about the side effect profile. Nausea is the most common, in roughly 25% to 44% of people depending on the drug and dose, and it happens mostly during dose increases. In STEP 1, 4.5% of people on semaglutide stopped because of stomach side effects. I would like to start at the lowest dose and go up only as I tolerate it.”

Those figures come from the Wegovy label, the Zepbound label and STEP 1. In the head-to-head SURMOUNT-5 trial, stomach side effects were the most common in both groups and were mostly mild to moderate. The labels also list serious risks to ask about, including pancreatitis, gallbladder problems, kidney injury from dehydration, and a boxed warning about thyroid C-cell tumors. People with a personal or family history of medullary thyroid cancer or MEN 2 should not take these drugs.

Having the actual numbers shows your doctor you have done your homework. For a full breakdown, see our side effects guide.

”You will just regain the weight when you stop.”

What to say: “I understand this is a long-term medication for most people, similar to blood pressure or cholesterol meds. I am prepared for that. I would rather manage a chronic condition with an effective medication than continue gaining weight.”

This is a valid concern. Weight regain after stopping GLP-1 medication is real. Our maintenance guide covers what happens when you stop and the strategies that help.

”I am not comfortable prescribing these.”

What to say: “I understand. Can you refer me to an endocrinologist or obesity medicine specialist who has more experience with GLP-1 prescribing? Or would you be open to me getting an evaluation from a telehealth provider that specializes in this?”

Some PCPs are genuinely not experienced enough with GLP-1s to prescribe them confidently. That is not a character flaw. It is a knowledge gap. An obesity medicine specialist or a GLP-1-focused telehealth provider will be more comfortable with these medications.

”Your BMI is not high enough.”

What to say: “The weight-loss approvals cover overweight with a weight-related condition, not just obesity. I have [condition]. Can we discuss whether I qualify?”

The main trials for Zepbound enrolled people with a BMI of 27 to under 30 if they had a weight-related condition such as dyslipidemia, hypertension, sleep apnea or heart disease. Your insurer may still set its own cutoffs.

The Telehealth Alternative

If your primary care doctor says no, or if the process feels too slow, telehealth providers that specialize in GLP-1 prescribing are a legitimate option. These are licensed clinicians doing online or video consultations and prescribing FDA-approved or compounded GLP-1 medications. The FDA notes that compounded versions are not FDA-approved.

The advantages of telehealth for GLP-1s:

• Faster access. Many telehealth providers advertise quick turnaround, though timing varies by company and state.
• Focus. These providers prescribe GLP-1s often and are used to titration schedules and side effect questions.
• No referral needed. You book directly.
• Cash-pay pricing. If insurance is a barrier, telehealth providers offer compounded and brand-name options at fixed monthly prices.

The trade-off is cost. You usually pay a program fee plus the medication out of pocket, and prices vary widely. See our cheapest GLP-1 online guide for a full price comparison, or browse the provider directory to compare options.

I went the telehealth route for my Mounjaro prescription after my PCP was unfamiliar with the titration protocol. The experience was straightforward: a video consult, medical history review, and a prescription within 2 days. Not everyone needs to go this route, but it is good to know it exists.

What Happens After You Get the Prescription

Getting the prescription is step one. Here is what comes next:

Insurance Prior Authorization

If your doctor prescribes a brand-name GLP-1 through insurance, expect a prior authorization process. Timing varies by insurer. Your doctor’s office submits documentation to your insurer, the insurer reviews it, and they either approve or deny. If denied, you can appeal. Our guide on copay cards and patient assistance explains how to reduce your out-of-pocket cost once approved.

First Dose and Titration

Injectable GLP-1 medications start at a low dose and increase (titrate) after at least 4 weeks on each step, per the Wegovy and Zepbound labels. The starting dose is not a maintenance dose. Follow the schedule your prescriber gives you. Expect some nausea, reduced appetite, and possibly changes in how food tastes. Our nausea management guide covers what actually works during this period.

Monitoring

There is no single required lab schedule in the labels. Your prescriber decides what to check based on your health. The Wegovy label says to monitor blood sugar in people with diabetes, and notes that routine calcitonin or thyroid ultrasound monitoring is of uncertain value. Ask your doctor what follow-up they plan, and report severe stomach pain, signs of dehydration or a lump in your neck right away.

Track Your Progress

I cannot overstate how useful it is to track body composition, not just weight. I got a DEXA scan at baseline and at 6 months on Mounjaro. Scale weight only tells part of the story. My DEXA showed I had lost 38 pounds of fat and only 7 pounds of lean mass, If you are interested in that data, I wrote about my 6-month DEXA results in detail.

The Bottom Line

Asking your doctor about GLP-1 medications like Ozempic or Mounjaro does not require a special script or a perfect pitch. It requires showing up prepared: know your BMI, your weight history, your comorbidities, and your insurance situation. Frame it as a medical conversation backed by data, not a personal request.

If your doctor says no, ask why. If the reason is medical, work with them. If the reason is unfamiliarity, ask for a referral or explore telehealth providers who specialize in GLP-1 prescribing. You have more options than you think.

FAQ

Do I need a specific BMI to ask my doctor about GLP-1 Ozempic or Mounjaro?

Wegovy and Zepbound are FDA-approved for weight management in adults with obesity, or overweight plus at least one weight-related condition. Their trials used BMI 30 or higher, or 27 or higher with a condition such as high blood pressure, high cholesterol or sleep apnea. You do not need to be at any specific weight to start the conversation.

Can my primary care doctor prescribe GLP-1 medications, or do I need a specialist?

Any licensed prescriber can prescribe GLP-1 medications. You do not need an endocrinologist or obesity specialist, though those doctors tend to have more experience with titration and side effect management. If your PCP is hesitant, a telehealth provider specializing in GLP-1s is another option.

What if my insurance denies coverage for GLP-1 medication?

You can appeal the denial, ask about the manufacturers’ self-pay programs (Lilly and Novo Nordisk both offer them), or use a cash-pay telehealth provider. See our GLP-1 without insurance guide for all the options.

How should I respond if my doctor recommends a different weight loss approach first?

Ask what specifically they recommend and for how long. If you have already tried what they are suggesting, share your history with dates and results. If they want you to try a structured program for 3 months before considering medication, that is reasonable. If they dismiss medication entirely without engaging with the clinical evidence, consider getting a second opinion.

Is it okay to mention a specific medication by name, or will that seem pushy?

Mentioning a specific medication is fine and actually helpful. Doctors expect patients to come in informed. Saying “I have been researching tirzepatide and semaglutide” shows you have done your homework. Just frame it as a question (“Would either of these be appropriate for me?”) rather than a demand.

Related

Guides:

• Doctor Won’t Increase Your Dose · GLP-1 Side Effects · Insurance Coverage
• Cheapest GLP-1 Online · GLP-1 Cost Guide · Cash Pay vs Insurance

Provider Reviews: Ro · Hims · Calibrate · Found

Compare: All Providers · Best GLP-1 Programs · All Guides

What we checked

This AI-assisted public-source desk check reviewed the current FDA labels for Ozempic, Wegovy, Mounjaro, Zepbound and Foundayo on DailyMed, the STEP 1, SURMOUNT-1 and SURMOUNT-5 papers on PubMed, the FDA page on unapproved GLP-1 drugs, and the self-pay pages on wegovy.com and zepbound.lilly.com on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.